Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Spectrum Pharmaceuticals Inc.

http://www.sppirx.com/

Latest From Spectrum Pharmaceuticals Inc.

Rising COVID-19 Disruption Of Korea's Global R&D

As the prolonged COVID-19 pandemic continues to take a toll globally, South Korean pharma firms’ overseas drug development activities are increasingly being disrupted by the impact.

Clinical Trials South Korea

Finance Watch: Billions In And Billions Out In Venture Capital Fundraising

Private Company Edition: The flood of venture capital into health care and life science firms continues with Perceptive closing a $1.1bn credit fund and Sanofi investing $50m in Jeito Capital. Also, Ambrx closed a $200m crossover round as biopharma remains on track for a record funding year.

Financing StartUps and SMEs

New Daiichi Structure Strengthens Oncology Focus

Japanese firm creates new US-based global organization that reaffirms strategic focus on oncology as main pillar of mid-term growth.

Business Strategies Cancer

Keeping Track: Incomplete Responses For Unusual Times; Qtrypta Is Latest CRL

Highlights from complete response letter news from the Pink Sheet’s US FDA Performance Tracker.

US FDA Performance Tracker Complete Response Letters
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Other Names / Subsidiaries
    • Allos Therapeutics, Inc.
    • OncoRx
    • Talon Therapeutics, Inc. (Hana Biosciences, Inc.)
UsernamePublicRestriction

Register